Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Niremia Collective is a venture capital firm based in Silicon Valley, founded in 2014 by Naoko Okumoto and Nichol Bradford. The firm focuses on enhancing human potential through technology, particularly in the areas of mental, emotional, and social health (MESH). Niremia aims to democratize access to wellbeing solutions and optimize outcomes for individuals and communities.
As of now, Niremia Collective manages a fund size of $22.5 million, specifically Fund I. The firm primarily invests in early-stage startups, emphasizing sectors such as healthcare, AI, longevity, and consumer products. Niremia has established a notable presence in the wellbeing technology sector, showcasing a commitment to driving innovations that improve health outcomes.
Headquartered in Palo Alto, California, Niremia Collective has built a diverse portfolio of companies that align with its mission. The firm continues to expand its reach and influence within the wellbeing technology space, actively seeking partnerships that share its vision for enhancing human potential.
Niremia Collective invests in early-stage startups that drive innovations in wellbeing technology. Their investment strategy encompasses a wide range of sectors, including Mental, Emotional, and Social Health (MESH), New Ways of Working, Healthy and Happy Aging, Human-centric Urban Design, Food Technology, Technologies for Living Environments, Women’s Health, Preventative Health, and Longevity.
The firm evaluates investment opportunities based on several criteria, including team quality, vision, market opportunity, minimum viable product (MVP) and traction, validation, and outcome potential. Niremia's geographic focus is primarily on North America, allowing them to tap into a vibrant startup ecosystem that aligns with their mission of enhancing human potential through technology.
Investors at Niremia Collective seek to partner with founders who demonstrate a strong commitment to improving wellbeing through innovative solutions. The firm’s emphasis on early-stage investments allows them to support startups from their inception, providing the necessary resources and guidance to help them succeed.
Niremia Collective has partnered with various startups in the wellbeing technology sector, showcasing a diverse portfolio that reflects its investment focus. Notable portfolio companies include:
This portfolio illustrates Niremia's commitment to investing in technologies that enhance mental, emotional, and social health, aligning with their overarching mission to democratize access to wellbeing solutions.
Naoko Okumoto: Co-founder and Managing Partner at Niremia Collective. Naoko has extensive experience in the investment sector and a strong background in technology and wellbeing.
Nichol Bradford: Co-founder and Partner at Niremia Collective. Nichol brings a wealth of knowledge in health technology and has a proven track record in supporting startups focused on wellbeing.
Hiroaki Kitano: Senior Executive Advisor at Niremia Collective. Hiroaki has a background in AI and healthcare, providing valuable insights into the firm's investment strategy.
Rene Caissie: Senior Advisor at Niremia Collective. Rene has significant experience in venture capital and a deep understanding of the wellbeing technology landscape.
To pitch Niremia Collective, founders should send an email to info@mysite.com. It is important to include a comprehensive deck that outlines the business model, market opportunity, and alignment with Niremia's investment focus on wellbeing technology.
Founders can expect a response within a few weeks, and warm introductions are preferred but not mandatory. Clear and concise communication is key to capturing the firm's interest.
In recent months, Niremia Collective has continued to expand its portfolio within the wellbeing technology sector. The firm has made several investments in innovative startups that align with its mission to enhance human potential through technology.
Notable activities include the addition of companies focused on mental health solutions and AI-driven health technologies. Niremia Collective remains committed to democratizing access to wellbeing solutions and optimizing outcomes for individuals and communities.
What are Niremia Collective's investment criteria?
Niremia Collective evaluates startups based on team quality, vision, market opportunity, minimum viable product (MVP) and traction, validation, and outcome potential. They prioritize companies that align with their focus on wellbeing technology.
How can I apply or pitch to Niremia Collective?
What makes Niremia Collective different from other investors?
Niremia Collective specifically targets the wellbeing technology sector, emphasizing mental, emotional, and social health. Their unique focus on enhancing human potential through technology sets them apart from other venture capital firms.
What is the geographic scope of Niremia Collective's investments?
The firm primarily invests in North America, allowing them to engage with a diverse range of startups in the wellbeing technology space.
What is the typical fund size and check size for Niremia Collective?
Niremia Collective's current fund size is $22.5 million, and they invest in early-stage startups at the pre-seed, seed, and seed-plus stages.
What kind of post-investment involvement can founders expect?
Niremia Collective actively supports its portfolio companies by providing resources, mentorship, and access to their network, helping startups navigate challenges and scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.